Comparative Biochemical Outcomes, Effectiveness and Tolerance of Densiron 68 and Oxane HD for the Management of Complicated Retinal Detachment

To compare biochemical outcomes, effectiveness, and tolerance of two high-density silicone oils (HDSOs), silicone oil- RMN3 (Oxane HD) and silicone oil-Densiron-68 (Densiron 68), for the management of complicated retinal detachment (RD) associated with inferior proliferative vitreoretinopathy (PVR)....

Full description

Saved in:
Bibliographic Details
Published in:Turk oftalmoloji gazetesi 2019-12, Vol.49 (6), p.334-341
Main Authors: Keilani, Chafik, Augstburger, Edouard, Robin, Mathieu, Beaugrand, Amélie, Ores, Raphaëlle, Sahel, José-Alain, Ayello-Scheer, Sarah
Format: Article
Language:English
Subjects:
Aged
Biochemistry
Care and treatment
complicated inferior retinal detachment
densiron® 68
Endotamponade - methods
Female
High definition television
high-density silicone oils
Humans
Male
Middle Aged
Original
oxane® hd
proliferative vitreoretinopathy
Retinal detachment
Retinal Detachment - etiology
Retinal Detachment - physiopathology
Retinal Detachment - surgery
Retrospective Studies
Silicone Oils - administration & dosage
Silicones
Surgery
Tıp
Treatment Outcome
Visual Acuity - physiology
Vitrectomy
Vitreoretinopathy, Proliferative - complications
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c611t-48db74e1184426bc6a0546ae898cd64c3a64b151c8e8df2a46309997b7e73f723
cites
container_end_page 341
container_issue 6
container_start_page 334
container_title Turk oftalmoloji gazetesi
container_volume 49
creator Keilani, Chafik
Augstburger, Edouard
Robin, Mathieu
Beaugrand, Amélie
Ores, Raphaëlle
Sahel, José-Alain
Ayello-Scheer, Sarah
description To compare biochemical outcomes, effectiveness, and tolerance of two high-density silicone oils (HDSOs), silicone oil- RMN3 (Oxane HD) and silicone oil-Densiron-68 (Densiron 68), for the management of complicated retinal detachment (RD) associated with inferior proliferative vitreoretinopathy (PVR). This was a retrospective, single-centre, comparative case series of 23 patients treated between September 2014 and June 2016. The main inclusion criteria were RD with inferior PVR receiving Oxane HD or Densiron 68 following pars plana vitrectomy. The main outcome measures were anatomical success, rate of RD recurrence, and best-corrected visual acuity (BCVA) at 6 months. Secondary outcomes were short-term complications. Twenty-three eyes were included: 16 eyes with Densiron 68 tamponade and 7 eyes with Oxane HD tamponade. Anatomical success under HDSO was significantly higher in the Densiron 68 group (100%) than in the Oxane HD group (42.8%) (p=0.0455). Recurrent RD was observed in 42.8% of eyes under Oxane HD, but in none of the patients under Densiron 68 (p=0.001). Six months after surgery, mean BVCA values (+/- standard deviation) with Densiron 68 and Oxane HD were 0.83±0.62 logMAR and 1.81±0.65 logMAR, respectively. BVCA was significantly better in the Densiron 68 group (p=0.006). No significant differences were observed with regard to intraocular pressure, emulsification, or intraocular inflammation. Densiron 68 appears to be more effective than Oxane HD for the management of RD associated with PVR. A randomized, controlled, interventional study is needed to demonstrate this difference.
doi_str_mv 10.4274/tjo.galenos.2019.24294
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_a27f40a0b10d4793931a0ad9f0faa46b</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A616630703</galeid><doaj_id>oai_doaj_org_article_a27f40a0b10d4793931a0ad9f0faa46b</doaj_id><sourcerecordid>A616630703</sourcerecordid><originalsourceid>FETCH-LOGICAL-c611t-48db74e1184426bc6a0546ae898cd64c3a64b151c8e8df2a46309997b7e73f723</originalsourceid><addsrcrecordid>eNptktFqFDEUhgdRtNS-QgkI4oW7JpNsZnIj1G61hUpB6nU4kznZzTKT1CRb9CV8ZjO7tXZBchE45z_fSX7-qjpldC7qRnzImzBfwYA-pHlNmZrXolbiWXVUM6FmbUPV8-qIcUpnVC7Uq-okpQ2llDWiprJ9Wb3irFV80aqj6vd5GO8gQnb3SD65YNY4OgMDudlmE0ZM78mFtWimvseUCPie3IYBI3iDJFiyRJ9cDJ7Idte8-QkeyeWS2BBJXiP5Ch5WOKLPk3zaN5QNGXvyDbPzZdcSM5j1pHhdvbAwJDx5uI-r758vbs8vZ9c3X67Oz65nRjKWZ6Ltu0YgY60QteyMBLoQErBVremlMByk6NiCmRbb3tYgJKdKqaZrsOG2qflxdbXn9gE2-i66EeIvHcDpXSHElYaYnRlQQ91YQYF2jPaiUVxxBhR6ZamFAu4K6-OedbftRuxN-UaE4QB62PFurVfhXkslGW1ZAbx7AMTwY4sp69Elg8NQjAzbpGvOa9pStmj-SV2PMAQ_OI96E7ax2Jj01fLi7FozxhY76pu9dEqKdt6GstxMZH0mmSyONJQX1fw_qnL6KQfBo3WlfjDw9snAurwir1MYttkFnw6Fci80MaQU0T46wqieYqxLjPVDjPUUY72LcRk8fern49jf0PI_zVDv0w</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2332080157</pqid></control><display><type>article</type><title>Comparative Biochemical Outcomes, Effectiveness and Tolerance of Densiron 68 and Oxane HD for the Management of Complicated Retinal Detachment</title><source>PubMed Central（OA）</source><source>Publicly Available Content Database</source><creator>Keilani, Chafik ; Augstburger, Edouard ; Robin, Mathieu ; Beaugrand, Amélie ; Ores, Raphaëlle ; Sahel, José-Alain ; Ayello-Scheer, Sarah</creator><contributor>İrkeç,Murat</contributor><creatorcontrib>Keilani, Chafik ; Augstburger, Edouard ; Robin, Mathieu ; Beaugrand, Amélie ; Ores, Raphaëlle ; Sahel, José-Alain ; Ayello-Scheer, Sarah ; İrkeç,Murat</creatorcontrib><description>To compare biochemical outcomes, effectiveness, and tolerance of two high-density silicone oils (HDSOs), silicone oil- RMN3 (Oxane HD) and silicone oil-Densiron-68 (Densiron 68), for the management of complicated retinal detachment (RD) associated with inferior proliferative vitreoretinopathy (PVR). This was a retrospective, single-centre, comparative case series of 23 patients treated between September 2014 and June 2016. The main inclusion criteria were RD with inferior PVR receiving Oxane HD or Densiron 68 following pars plana vitrectomy. The main outcome measures were anatomical success, rate of RD recurrence, and best-corrected visual acuity (BCVA) at 6 months. Secondary outcomes were short-term complications. Twenty-three eyes were included: 16 eyes with Densiron 68 tamponade and 7 eyes with Oxane HD tamponade. Anatomical success under HDSO was significantly higher in the Densiron 68 group (100%) than in the Oxane HD group (42.8%) (p=0.0455). Recurrent RD was observed in 42.8% of eyes under Oxane HD, but in none of the patients under Densiron 68 (p=0.001). Six months after surgery, mean BVCA values (+/- standard deviation) with Densiron 68 and Oxane HD were 0.83±0.62 logMAR and 1.81±0.65 logMAR, respectively. BVCA was significantly better in the Densiron 68 group (p=0.006). No significant differences were observed with regard to intraocular pressure, emulsification, or intraocular inflammation. Densiron 68 appears to be more effective than Oxane HD for the management of RD associated with PVR. A randomized, controlled, interventional study is needed to demonstrate this difference.</description><identifier>ISSN: 1300-0659</identifier><identifier>ISSN: 2149-8709</identifier><identifier>ISSN: 2149-8695</identifier><identifier>EISSN: 2149-8709</identifier><identifier>EISSN: 2147-2661</identifier><identifier>DOI: 10.4274/tjo.galenos.2019.24294</identifier><identifier>PMID: 31893589</identifier><language>eng</language><publisher>Turkey: Galenos Yayinevi Tic. Ltd</publisher><subject>Aged ; Biochemistry ; Care and treatment ; complicated inferior retinal detachment ; densiron® 68 ; Endotamponade - methods ; Female ; High definition television ; high-density silicone oils ; Humans ; Male ; Middle Aged ; Original ; oxane® hd ; proliferative vitreoretinopathy ; Retinal detachment ; Retinal Detachment - etiology ; Retinal Detachment - physiopathology ; Retinal Detachment - surgery ; Retrospective Studies ; Silicone Oils - administration &amp; dosage ; Silicones ; Surgery ; Tıp ; Treatment Outcome ; Visual Acuity - physiology ; Vitrectomy ; Vitreoretinopathy, Proliferative - complications</subject><ispartof>Turk oftalmoloji gazetesi, 2019-12, Vol.49 (6), p.334-341</ispartof><rights>COPYRIGHT 2019 Galenos Yayinevi Tic. Ltd.</rights><rights>Copyright 2019 by Turkish Ophthalmological Association | Turkish Journal of Ophthalmology, published by Galenos Publishing House. 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c611t-48db74e1184426bc6a0546ae898cd64c3a64b151c8e8df2a46309997b7e73f723</citedby><orcidid>0000-0003-2907-4452 ; 0000-0001-6937-0198 ; 0000-0002-7639-8030 ; 0000-0001-5321-9661 ; 0000-0003-4423-6632 ; 0000-0003-3600-3599 ; 0000-0002-7296-2343</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961081/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961081/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31893589$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>İrkeç,Murat</contributor><creatorcontrib>Keilani, Chafik</creatorcontrib><creatorcontrib>Augstburger, Edouard</creatorcontrib><creatorcontrib>Robin, Mathieu</creatorcontrib><creatorcontrib>Beaugrand, Amélie</creatorcontrib><creatorcontrib>Ores, Raphaëlle</creatorcontrib><creatorcontrib>Sahel, José-Alain</creatorcontrib><creatorcontrib>Ayello-Scheer, Sarah</creatorcontrib><title>Comparative Biochemical Outcomes, Effectiveness and Tolerance of Densiron 68 and Oxane HD for the Management of Complicated Retinal Detachment</title><title>Turk oftalmoloji gazetesi</title><addtitle>Turk J Ophthalmol</addtitle><description>To compare biochemical outcomes, effectiveness, and tolerance of two high-density silicone oils (HDSOs), silicone oil- RMN3 (Oxane HD) and silicone oil-Densiron-68 (Densiron 68), for the management of complicated retinal detachment (RD) associated with inferior proliferative vitreoretinopathy (PVR). This was a retrospective, single-centre, comparative case series of 23 patients treated between September 2014 and June 2016. The main inclusion criteria were RD with inferior PVR receiving Oxane HD or Densiron 68 following pars plana vitrectomy. The main outcome measures were anatomical success, rate of RD recurrence, and best-corrected visual acuity (BCVA) at 6 months. Secondary outcomes were short-term complications. Twenty-three eyes were included: 16 eyes with Densiron 68 tamponade and 7 eyes with Oxane HD tamponade. Anatomical success under HDSO was significantly higher in the Densiron 68 group (100%) than in the Oxane HD group (42.8%) (p=0.0455). Recurrent RD was observed in 42.8% of eyes under Oxane HD, but in none of the patients under Densiron 68 (p=0.001). Six months after surgery, mean BVCA values (+/- standard deviation) with Densiron 68 and Oxane HD were 0.83±0.62 logMAR and 1.81±0.65 logMAR, respectively. BVCA was significantly better in the Densiron 68 group (p=0.006). No significant differences were observed with regard to intraocular pressure, emulsification, or intraocular inflammation. Densiron 68 appears to be more effective than Oxane HD for the management of RD associated with PVR. A randomized, controlled, interventional study is needed to demonstrate this difference.</description><subject>Aged</subject><subject>Biochemistry</subject><subject>Care and treatment</subject><subject>complicated inferior retinal detachment</subject><subject>densiron® 68</subject><subject>Endotamponade - methods</subject><subject>Female</subject><subject>High definition television</subject><subject>high-density silicone oils</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Original</subject><subject>oxane® hd</subject><subject>proliferative vitreoretinopathy</subject><subject>Retinal detachment</subject><subject>Retinal Detachment - etiology</subject><subject>Retinal Detachment - physiopathology</subject><subject>Retinal Detachment - surgery</subject><subject>Retrospective Studies</subject><subject>Silicone Oils - administration &amp; dosage</subject><subject>Silicones</subject><subject>Surgery</subject><subject>Tıp</subject><subject>Treatment Outcome</subject><subject>Visual Acuity - physiology</subject><subject>Vitrectomy</subject><subject>Vitreoretinopathy, Proliferative - complications</subject><issn>1300-0659</issn><issn>2149-8709</issn><issn>2149-8695</issn><issn>2149-8709</issn><issn>2147-2661</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNptktFqFDEUhgdRtNS-QgkI4oW7JpNsZnIj1G61hUpB6nU4kznZzTKT1CRb9CV8ZjO7tXZBchE45z_fSX7-qjpldC7qRnzImzBfwYA-pHlNmZrXolbiWXVUM6FmbUPV8-qIcUpnVC7Uq-okpQ2llDWiprJ9Wb3irFV80aqj6vd5GO8gQnb3SD65YNY4OgMDudlmE0ZM78mFtWimvseUCPie3IYBI3iDJFiyRJ9cDJ7Idte8-QkeyeWS2BBJXiP5Ch5WOKLPk3zaN5QNGXvyDbPzZdcSM5j1pHhdvbAwJDx5uI-r758vbs8vZ9c3X67Oz65nRjKWZ6Ltu0YgY60QteyMBLoQErBVremlMByk6NiCmRbb3tYgJKdKqaZrsOG2qflxdbXn9gE2-i66EeIvHcDpXSHElYaYnRlQQ91YQYF2jPaiUVxxBhR6ZamFAu4K6-OedbftRuxN-UaE4QB62PFurVfhXkslGW1ZAbx7AMTwY4sp69Elg8NQjAzbpGvOa9pStmj-SV2PMAQ_OI96E7ax2Jj01fLi7FozxhY76pu9dEqKdt6GstxMZH0mmSyONJQX1fw_qnL6KQfBo3WlfjDw9snAurwir1MYttkFnw6Fci80MaQU0T46wqieYqxLjPVDjPUUY72LcRk8fern49jf0PI_zVDv0w</recordid><startdate>20191201</startdate><enddate>20191201</enddate><creator>Keilani, Chafik</creator><creator>Augstburger, Edouard</creator><creator>Robin, Mathieu</creator><creator>Beaugrand, Amélie</creator><creator>Ores, Raphaëlle</creator><creator>Sahel, José-Alain</creator><creator>Ayello-Scheer, Sarah</creator><general>Galenos Yayinevi Tic. Ltd</general><general>Türk Oftalmoloji Derneği</general><general>Galenos Publishing</general><general>Galenos Yayinevi</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IEBAR</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-2907-4452</orcidid><orcidid>https://orcid.org/0000-0001-6937-0198</orcidid><orcidid>https://orcid.org/0000-0002-7639-8030</orcidid><orcidid>https://orcid.org/0000-0001-5321-9661</orcidid><orcidid>https://orcid.org/0000-0003-4423-6632</orcidid><orcidid>https://orcid.org/0000-0003-3600-3599</orcidid><orcidid>https://orcid.org/0000-0002-7296-2343</orcidid></search><sort><creationdate>20191201</creationdate><title>Comparative Biochemical Outcomes, Effectiveness and Tolerance of Densiron 68 and Oxane HD for the Management of Complicated Retinal Detachment</title><author>Keilani, Chafik ; Augstburger, Edouard ; Robin, Mathieu ; Beaugrand, Amélie ; Ores, Raphaëlle ; Sahel, José-Alain ; Ayello-Scheer, Sarah</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c611t-48db74e1184426bc6a0546ae898cd64c3a64b151c8e8df2a46309997b7e73f723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Aged</topic><topic>Biochemistry</topic><topic>Care and treatment</topic><topic>complicated inferior retinal detachment</topic><topic>densiron® 68</topic><topic>Endotamponade - methods</topic><topic>Female</topic><topic>High definition television</topic><topic>high-density silicone oils</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Original</topic><topic>oxane® hd</topic><topic>proliferative vitreoretinopathy</topic><topic>Retinal detachment</topic><topic>Retinal Detachment - etiology</topic><topic>Retinal Detachment - physiopathology</topic><topic>Retinal Detachment - surgery</topic><topic>Retrospective Studies</topic><topic>Silicone Oils - administration &amp; dosage</topic><topic>Silicones</topic><topic>Surgery</topic><topic>Tıp</topic><topic>Treatment Outcome</topic><topic>Visual Acuity - physiology</topic><topic>Vitrectomy</topic><topic>Vitreoretinopathy, Proliferative - complications</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Keilani, Chafik</creatorcontrib><creatorcontrib>Augstburger, Edouard</creatorcontrib><creatorcontrib>Robin, Mathieu</creatorcontrib><creatorcontrib>Beaugrand, Amélie</creatorcontrib><creatorcontrib>Ores, Raphaëlle</creatorcontrib><creatorcontrib>Sahel, José-Alain</creatorcontrib><creatorcontrib>Ayello-Scheer, Sarah</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Idealonline online kütüphane - Journals</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Turk oftalmoloji gazetesi</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Keilani, Chafik</au><au>Augstburger, Edouard</au><au>Robin, Mathieu</au><au>Beaugrand, Amélie</au><au>Ores, Raphaëlle</au><au>Sahel, José-Alain</au><au>Ayello-Scheer, Sarah</au><au>İrkeç,Murat</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparative Biochemical Outcomes, Effectiveness and Tolerance of Densiron 68 and Oxane HD for the Management of Complicated Retinal Detachment</atitle><jtitle>Turk oftalmoloji gazetesi</jtitle><addtitle>Turk J Ophthalmol</addtitle><date>2019-12-01</date><risdate>2019</risdate><volume>49</volume><issue>6</issue><spage>334</spage><epage>341</epage><pages>334-341</pages><issn>1300-0659</issn><issn>2149-8709</issn><issn>2149-8695</issn><eissn>2149-8709</eissn><eissn>2147-2661</eissn><abstract>To compare biochemical outcomes, effectiveness, and tolerance of two high-density silicone oils (HDSOs), silicone oil- RMN3 (Oxane HD) and silicone oil-Densiron-68 (Densiron 68), for the management of complicated retinal detachment (RD) associated with inferior proliferative vitreoretinopathy (PVR). This was a retrospective, single-centre, comparative case series of 23 patients treated between September 2014 and June 2016. The main inclusion criteria were RD with inferior PVR receiving Oxane HD or Densiron 68 following pars plana vitrectomy. The main outcome measures were anatomical success, rate of RD recurrence, and best-corrected visual acuity (BCVA) at 6 months. Secondary outcomes were short-term complications. Twenty-three eyes were included: 16 eyes with Densiron 68 tamponade and 7 eyes with Oxane HD tamponade. Anatomical success under HDSO was significantly higher in the Densiron 68 group (100%) than in the Oxane HD group (42.8%) (p=0.0455). Recurrent RD was observed in 42.8% of eyes under Oxane HD, but in none of the patients under Densiron 68 (p=0.001). Six months after surgery, mean BVCA values (+/- standard deviation) with Densiron 68 and Oxane HD were 0.83±0.62 logMAR and 1.81±0.65 logMAR, respectively. BVCA was significantly better in the Densiron 68 group (p=0.006). No significant differences were observed with regard to intraocular pressure, emulsification, or intraocular inflammation. Densiron 68 appears to be more effective than Oxane HD for the management of RD associated with PVR. A randomized, controlled, interventional study is needed to demonstrate this difference.</abstract><cop>Turkey</cop><pub>Galenos Yayinevi Tic. Ltd</pub><pmid>31893589</pmid><doi>10.4274/tjo.galenos.2019.24294</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-2907-4452</orcidid><orcidid>https://orcid.org/0000-0001-6937-0198</orcidid><orcidid>https://orcid.org/0000-0002-7639-8030</orcidid><orcidid>https://orcid.org/0000-0001-5321-9661</orcidid><orcidid>https://orcid.org/0000-0003-4423-6632</orcidid><orcidid>https://orcid.org/0000-0003-3600-3599</orcidid><orcidid>https://orcid.org/0000-0002-7296-2343</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1300-0659
ispartof Turk oftalmoloji gazetesi, 2019-12, Vol.49 (6), p.334-341
issn 1300-0659
2149-8709
2149-8695
2149-8709
2147-2661
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_a27f40a0b10d4793931a0ad9f0faa46b
source PubMed Central（OA）; Publicly Available Content Database
subjects Aged
Biochemistry
Care and treatment
complicated inferior retinal detachment
densiron® 68
Endotamponade - methods
Female
High definition television
high-density silicone oils
Humans
Male
Middle Aged
Original
oxane® hd
proliferative vitreoretinopathy
Retinal detachment
Retinal Detachment - etiology
Retinal Detachment - physiopathology
Retinal Detachment - surgery
Retrospective Studies
Silicone Oils - administration & dosage
Silicones
Surgery
Tıp
Treatment Outcome
Visual Acuity - physiology
Vitrectomy
Vitreoretinopathy, Proliferative - complications
title Comparative Biochemical Outcomes, Effectiveness and Tolerance of Densiron 68 and Oxane HD for the Management of Complicated Retinal Detachment
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T13%3A12%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparative%20Biochemical%20Outcomes,%20Effectiveness%20and%20Tolerance%20of%20Densiron%2068%20and%20Oxane%20HD%20for%20the%20Management%20of%20Complicated%20Retinal%20Detachment&rft.jtitle=Turk%20oftalmoloji%20gazetesi&rft.au=Keilani,%20Chafik&rft.date=2019-12-01&rft.volume=49&rft.issue=6&rft.spage=334&rft.epage=341&rft.pages=334-341&rft.issn=1300-0659&rft.eissn=2149-8709&rft_id=info:doi/10.4274/tjo.galenos.2019.24294&rft_dat=%3Cgale_doaj_%3EA616630703%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c611t-48db74e1184426bc6a0546ae898cd64c3a64b151c8e8df2a46309997b7e73f723%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2332080157&rft_id=info:pmid/31893589&rft_galeid=A616630703&rfr_iscdi=true